Mine Safety and Health Research Advisory Committee, National Institute for Occupational Safety and Health (MSHRAC, NIOSH), 17665-17666 [2017-07324]

Download as PDF Federal Register / Vol. 82, No. 69 / Wednesday, April 12, 2017 / Notices mstockstill on DSK30JT082PROD with NOTICES information collection requirement concerning acquisition of helium. A notice was published in the Federal Register at 81 FR 83844 on November 22, 2016. No comments were received. DATES: Submit comments on or before May 12, 2017. ADDRESSES: Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: Office of Information and Regulatory Affairs of OMB, Attention: Desk Officer for GSA, Room 10236, NEOB, Washington, DC 20503. Additionally submit a copy to GSA by any of the following methods: • Regulations.gov: https:// www.regulations.gov. Submit comments via the Federal eRulemaking portal by searching the OMB control number 9000–0113. Select the link ‘‘Comment Now’’ that corresponds with ‘‘Information Collection 9000–0113, Acquisition of Helium’’, Follow the instructions provided on the screen. Please include your name, company name (if any), and ‘‘Information Collection 9000–0113, Acquisition of Helium’’, on your attached document. • Mail: General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW., Washington, DC 20405. ATTN: Ms. Sosa/IC 9000–0113, Acquisition of Helium. Instructions: Please submit comments only and cite Information Collection 9000–0113, Acquisition of Helium, in all correspondence related to this collection. Comments received generally will be posted without change to https:// www.regulations.gov, including any personal and/or business confidential information provided. To confirm receipt of your comment(s), please check www.regulations.gov, approximately two to three days after submission to verify posting (except allow 30 days for posting of comments submitted by mail). FOR FURTHER INFORMATION CONTACT: Ms. Mahruba Uddowla, Procurement Analyst, Office of Governmentwide Acquisition Policy, GSA, via telephone 703–605–2868 or via email to mahruba.uddowla@gsa.gov. SUPPLEMENTARY INFORMATION: A. Purpose The Helium Act (Pub. L. 86–777) (50 U.S.C. 167a, et seq.) and the Department of the Interior’s implementing regulations (30 CFR parts 601 and 602) require Federal agencies to procure all major helium requirements from the VerDate Sep<11>2014 18:45 Apr 11, 2017 Jkt 241001 Bureau of Land Management, Department of the Interior. FAR 8.5, Acquisition of Helium, and the clause 52.208–8 Required Sources for Helium and Helium Usage Data, requires that the Contractor provide to the Contracting Officer the following data within 10 days after the Contractor or subcontractor receives a delivery of helium from a Federal helium supplier; (i) The name of the supplier; (ii) The amount of helium purchased; (iii) The delivery date(s); and (iv) the location where the helium was used. Such information will facilitate enforcement of the requirements of the Helium Act and the contractual provisions requiring the use of Government helium by agency contractors. The information is used in administration of certain Federal contracts to ensure contractor compliance with contract clauses. Without the information, the required use of Government helium cannot be monitored and enforced effectively. The FAR requires that the contractor provide helium purchase information 10 days after delivery from a federal helium supplier, not for the contractor to forecast what they are going to purchase. B. Annual Reporting Burden In consultation with subject matter experts at the Department of the Interior, Bureau of Land Management, Helium Operations, the number of estimated responses per year was verified as being within an acceptable range, as was the average time required to read and prepare information which was estimated at 1 hour per response. Respondents: 26. Responses per Respondent: 1. Total Responses: 26. Hours per Response: 1. Total Burden Hours: 26. C. Public Comments Public comments are particularly invited on: Whether this collection of information is necessary for the proper performance of functions of the FAR, and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected; and ways in which we can minimize the burden of the collection of information on those who are to respond, through the use of appropriate technological collection techniques or other forms of information technology. Obtaining Copies of Proposals: Requesters may obtain a copy of the PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 17665 information collection documents from the General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW., Washington, DC 20405, telephone 202–501–4755. Please cite OMB Control No. 9000–0113, Acquisition of Helium, in all correspondence. Dated: April 6, 2017. Lorin S. Curit, Director, Federal Acquisition Policy Division, Office of Governmentwide Acquisition Policy, Office of Acquisition Policy, Office of Governmentwide Policy. [FR Doc. 2017–07329 Filed 4–11–17; 8:45 am] BILLING CODE 6820–EP–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Mine Safety and Health Research Advisory Committee, National Institute for Occupational Safety and Health (MSHRAC, NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: Times and Dates: 9:00 a.m.–2:30 p.m., EDT, May 9, 2017; 8:30 a.m.–12:00 p.m., EDT, May 10, 2017. Place: National Institute for Occupational Safety and Health, Morgantown, WV Facility, 1095 Willowdale Road, Morgantown, WV 26505. Teleconference is also available. If you wish to attend in person or by phone, please contact Marie Chovanec by email at MChovanec@cdc.gov or by phone at 412–386–5302 at least 5 business days in advance of the meeting. Status: Open to public, limited only by the space available. The meeting room accommodates approximately 45 people. Purpose: This committee is charged with providing advice to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NIOSH, on priorities in mine safety and health research, including grants and contracts for such research, 30 U.S.C. 812(b)(2), Section 102(b)(2). Matters for Discussion: The meeting will focus on mining safety and health research projects and outcomes, including dust and ventilation research, work organization and safety culture research, breathing air supply research, an update on partnerships, health exposure/assessment/monitoring team E:\FR\FM\12APN1.SGM 12APN1 17666 Federal Register / Vol. 82, No. 69 / Wednesday, April 12, 2017 / Notices research, miner health program, and hazard recognition project for stone, sand and gravel mines. The meeting will also include updates from the National Personal Protective Technology Laboratory and the Respiratory Health Division. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Jeffrey H. Welsh, Designated Federal Officer, MSHRAC, NIOSH, CDC, 626 Cochrans Mill Road, Pittsburgh, PA 15236, telephone 412–386–4040, fax 412–386–6614. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2017–07324 Filed 4–11–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK30JT082PROD with NOTICES Board of Scientific Counselors, Office of Public Health Preparedness and Response, (BSC, OPHPR) In accordance with section 10 (a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 10:00 a.m.–5:00 p.m., EDT, May 10, 2017 8:30 a.m.–3:30 p.m., EDT, May 11, 2017 Place: Centers for Disease Control and Prevention (CDC), Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road NE., Atlanta, Georgia 30333 Status: Open to the public limited only by the space available. The meeting room will accommodate up to 75 people. Public participants should preregister for the meeting as described below. Members of the public that wish to attend this meeting in person should pre-register by submitting the following information by email, facsimile, or phone (see Contact Person for More Information) no later than 12:00 noon (EDT) on Tuesday, May 3, 2017: VerDate Sep<11>2014 19:24 Apr 11, 2017 Jkt 241001 • • • • • Full Name Organizational Affiliation Complete Mailing Address Citizenship Phone Number or Email Address Web conferencing information: Web ID: https:// adobeconnect.cdc.gov/r7mcyvjvzdh/. Dial in number: 800–369–1179 Participant passcode: 6329989. Purpose: This Board is charged with providing advice and guidance to the Secretary, Department of Health and Human Services (HHS), the Assistant Secretary for Health (ASH), the Director, Centers for Disease Control and Prevention (CDC), and the Director, Office of Public Health Preparedness and Response (OPHPR), concerning strategies and goals for the programs and research within OPHPR, monitoring the overall strategic direction and focus of the OPHPR Divisions and Offices, and administration and oversight of peer review for OPHPR scientific programs. For additional information about the Board, please visit: https:// www.cdc.gov/phpr/science/ counselors.htm. Matters for Discussion: Day one of the meeting will cover briefings and BSC deliberation on the following topics: interval updates from OPHPR Divisions and Offices; establishing a BSC working group to address biological agent containment; federal and state perspectives on the opioid overdose epidemic as a public health emergency; and BSC liaison representative updates to the Board highlighting organizational activities relevant to the OPHPR mission. Day two of the meeting will cover briefings and BSC deliberation on the following topics: OPHPR policy agenda update; natural disaster preparedness and response; global health security; and perspectives on CDC as a response organization. Contact Person for More Information: Dometa Ouisley, Office of Science and Public Health Practice, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop D–44, Atlanta, Georgia 30333, Telephone: (404) 639–7450; Facsimile: (404)471– 8772; Email: OPHPR.BSC.Questions@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Prevention, and Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Service Office, Centers for Disease Control and Prevention. [FR Doc. 2017–07325 Filed 4–11–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5:00 p.m., EDT, May 3, 2017; 8:30 a.m.–12:00 p.m., EDT, May 4, 2017. Place: CDC, Global Communications Center, 1600 Clifton Road NE., Building 19, Auditorium B3, Atlanta, Georgia 30329. Status: The meeting is open to the public, limited only by the space available. The meeting room will accommodate up to 100 people. Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters for Discussion: The meeting will include updates from CDC’s infectious disease national centers; reports from the BSC’s Food Safety Modernization Act Surveillance Working Group and Infectious Disease Laboratory Working Group; and focused discussions on priority emerging infectious diseases including antimicrobial resistance, influenza, and selected zoonotic and vector-borne diseases. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton E:\FR\FM\12APN1.SGM 12APN1

Agencies

[Federal Register Volume 82, Number 69 (Wednesday, April 12, 2017)]
[Notices]
[Pages 17665-17666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07324]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Mine Safety and Health Research Advisory Committee, National 
Institute for Occupational Safety and Health (MSHRAC, NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:
    Times and Dates: 9:00 a.m.-2:30 p.m., EDT, May 9, 2017; 8:30 a.m.-
12:00 p.m., EDT, May 10, 2017.
    Place: National Institute for Occupational Safety and Health, 
Morgantown, WV Facility, 1095 Willowdale Road, Morgantown, WV 26505. 
Teleconference is also available. If you wish to attend in person or by 
phone, please contact Marie Chovanec by email at MChovanec@cdc.gov or 
by phone at 412-386-5302 at least 5 business days in advance of the 
meeting.
    Status: Open to public, limited only by the space available. The 
meeting room accommodates approximately 45 people.
    Purpose: This committee is charged with providing advice to the 
Secretary, Department of Health and Human Services; the Director, CDC; 
and the Director, NIOSH, on priorities in mine safety and health 
research, including grants and contracts for such research, 30 U.S.C. 
812(b)(2), Section 102(b)(2).
    Matters for Discussion: The meeting will focus on mining safety and 
health research projects and outcomes, including dust and ventilation 
research, work organization and safety culture research, breathing air 
supply research, an update on partnerships, health exposure/assessment/
monitoring team

[[Page 17666]]

research, miner health program, and hazard recognition project for 
stone, sand and gravel mines. The meeting will also include updates 
from the National Personal Protective Technology Laboratory and the 
Respiratory Health Division.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Jeffrey H. Welsh, Designated 
Federal Officer, MSHRAC, NIOSH, CDC, 626 Cochrans Mill Road, 
Pittsburgh, PA 15236, telephone 412-386-4040, fax 412-386-6614.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 2017-07324 Filed 4-11-17; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.